Skip to content
10-Q

Quarterly Report

ANEBULO PHARMACEUTICALS, INC. ANEB

0001493152-26-006446

← back to feed
Filed
Feb 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Feb 6, 2026 40.78M sh
Shares Diluted Q2 2026 · Dec 31, 2025 41.08M sh
Shares Diluted Q2 2026 · Dec 31, 2025 41.08M sh
Shares Diluted Q2 2026 · Dec 31, 2024 27.42M sh
Shares Diluted Q2 2026 · Dec 31, 2024 26.67M sh
Operating Cash Flow Q2 2026 · Dec 31, 2025 −$2.59M
Operating Cash Flow Q2 2026 · Dec 31, 2024 −$3.1M
Cash And Equivalents Q2 2026 · Dec 31, 2025 $9.04M
Cash And Equivalents Q2 2026 · Jun 30, 2025 $11.63M
Stockholders Equity Q2 2026 · Dec 31, 2025 $7.94M
Stockholders Equity Q2 2026 · Sep 30, 2025 $9.74M
Stockholders Equity Q2 2026 · Jun 30, 2025 $11.66M
Stockholders Equity Q2 2026 · Dec 31, 2024 $14.96M
Stockholders Equity Q2 2026 · Sep 30, 2024 $1.9M
Stockholders Equity Q2 2026 · Jun 30, 2024 $3.81M
Total Liabilities Q2 2026 · Dec 31, 2025 $1.49M
Total Liabilities Q2 2026 · Jun 30, 2025 $487.69K
Current Assets Q2 2026 · Dec 31, 2025 $9.27M
Current Assets Q2 2026 · Jun 30, 2025 $11.96M
Total Assets Q2 2026 · Dec 31, 2025 $9.42M
Total Assets Q2 2026 · Jun 30, 2025 $12.15M
Eps Diluted Q2 2026 · Dec 31, 2025 −$0.05
Eps Diluted Q2 2026 · Dec 31, 2025 −$0.10
Eps Diluted Q2 2026 · Dec 31, 2024 −$0.09
Eps Diluted Q2 2026 · Dec 31, 2024 −$0.17
Eps Basic Q2 2026 · Dec 31, 2025 −$0.05
Eps Basic Q2 2026 · Dec 31, 2025 −$0.10
Eps Basic Q2 2026 · Dec 31, 2024 −$0.09
Eps Basic Q2 2026 · Dec 31, 2024 −$0.17
Sga Expense Q2 2026 · Dec 31, 2025 $1.46M
Sga Expense Q2 2026 · Dec 31, 2025 $2.91M
Sga Expense Q2 2026 · Dec 31, 2024 $1.37M
Sga Expense Q2 2026 · Dec 31, 2024 $2.46M
Rd Expense Q2 2026 · Dec 31, 2025 $1.16M
Rd Expense Q2 2026 · Dec 31, 2025 $1.97M
Rd Expense Q2 2026 · Dec 31, 2024 $1.22M
Rd Expense Q2 2026 · Dec 31, 2024 $2.54M
Net Income Q2 2026 · Dec 31, 2025 −$2M
Net Income Q2 2026 · Dec 31, 2025 −$4.16M
Net Income Q2 2026 · Sep 30, 2025 −$2.16M
Net Income Q2 2026 · Dec 31, 2024 −$2.46M
Net Income Q2 2026 · Dec 31, 2024 −$4.66M
Net Income Q2 2026 · Sep 30, 2024 −$2.2M
Operating Income Q2 2026 · Dec 31, 2025 −$2.62M
Operating Income Q2 2026 · Dec 31, 2025 −$4.88M
Operating Income Q2 2026 · Dec 31, 2024 −$2.59M
Operating Income Q2 2026 · Dec 31, 2024 −$5M